Since their first clinical application in 1974, percutaneous liver puncture biliary angiography needles (PTC Needles) have become a fundamental tool for the diagnosis and treatment of biliary diseases. As a professional manufacturer of PTC needles, we deeply understand the evolution and innovation of this technology in clinical practice. This article will comprehensively elaborate on the key role of PTC needles in the diagnosis and treatment of various biliary diseases from a clinical application perspective, as well as how manufacturers support clinical needs through product innovation.

Biliary Angiography: The Gold Standard for Accurate Diagnosis

PTC was originally designed for biliary angiography and is still the "gold standard" for diagnosing obstructive biliary diseases. Compared with ERCP (Endoscopic Retrograde Cholangiopancreatography), PTC angiography has unique advantages:

Technical features:

• Direct puncture method: Under ultrasound or X-ray guidance, percutaneous and transhepatic puncture of the intrahepatic bile ducts
• Real-time imaging: After injecting contrast agent, the entire biliary system is clearly imaged
• Pressure measurement: Can simultaneously measure biliary pressure and diagnose Oddi sphincter dysfunction

Clinical indications:

• Etiological diagnosis of obstructive jaundice: Sensitivity 92-98%, specificity 95-100%
• Localization of intrahepatic bile duct stones: Especially for cases where ERCP fails
• Evaluation of biliary tract injury: Precise assessment of postoperative bile leakage and biliary stenosis
• Diagnosis of congenital biliary malformations: Caroli disease, biliary atresia, etc.

Technological innovation:

• Modern PTC needle manufacturers have developed dedicated products for angiography needs:
• Micro-puncture system: 21G fine needle (0.8mm) combined with 0.018-inch guidewire, reducing the risk of bleeding
• Coaxial puncture needle: Outer tube provides a stable channel, and the inner needle can be repeatedly punctured for attempts
• Echo-enhanced needle: Special coating on the needle body, clearly visible under ultrasound

Studies show that using modern PTC needles for biliary angiography, the technical success rate can reach 95-99%, and the incidence of major complications is reduced to below 1.5%.

Biliary Drainage: A Leap from Saving Lives to Improving Quality of Life

Percutaneous liver puncture biliary drainage (PTBD) is an important treatment method for malignant obstructive jaundice. PTC needles play a key role in this process:

Drainage technology evolution:

• External drainage: Simply draining bile to the outside to relieve jaundice
• Internal and external drainage: The drainage tube passes through the obstructive segment, and some bile enters the intestine
• Internal stent placement: Metal or plastic stent to maintain biliary patency

Clinical value:

• Preoperative reduction of jaundice: Reducing surgical risks, serum bilirubin can drop by more than 50%
• Palliative treatment: Malignant obstruction that cannot be surgically treated, median survival time is prolonged by 3-6 months
• Infection control: Emergency decompression for acute suppurative cholangitis, mortality rate from 60% to 10%

Product innovation:

• Manufacturers have developed dedicated PTC needles for drainage needs:
• One-step puncture kit: Integrated design for puncture, angiography, and catheter insertion
• Steerable puncture needle: Nickel-titanium alloy needle body, adjustable direction during surgery
• Large-cavity drainage needle: 8-10Fr diameter, suitable for high-viscosity bile drainage

Tissue Biopsy: Key for Precise Pathological Diagnosis

When imaging examinations cannot clearly determine the nature of the lesion, PTC-guided biopsy becomes the decisive diagnostic method:

Biopsy techniques:

• Fine needle aspiration biopsy (FNA): 22-25G fine needle, cytological diagnosis
• Cutting needle biopsy: 18-20G Tru-Cut needle, tissue pathological diagnosis
• Coaxial biopsy system: Outer tube establishes a channel, multiple sampling

Clinical application:

• Diagnosis of biliary cancer: Sensitivity 85-95%, specificity close to 100%
• Differentiation of hilar masses: Distinguishing biliary cancer, liver cancer, and metastatic cancer
• Lymph node sampling: Evaluation of liver node metastasis
• Unexplained biliary stenosis: Excluding malignant lesions

Technological innovation:

• Ultrasound elastography guidance: Real-time assessment of tissue hardness, selection of the best biopsy site
• Radiofrequency marking needle: Marks the lesion during biopsy, facilitating subsequent treatment positioning
• Liquid biopsy needle: Collects both tissue samples and bile simultaneously, conducting comprehensive analyses of cytology, biochemistry, and microbiology

Stent Placement: Minimally Invasive Solution for Biliary Obstruction

Percutaneous transhepatic biliary stent placement has become the preferred treatment option for patients who are not suitable for surgery:

Stent types:

• Metal stent: Self-expanding metal stent (SEMS), with a patency period of 6-9 months
• Plastic stent: Reusable, low cost, with a patency period of 3-4 months
• Membrane stent: Prevents tumor growth inward, but has a higher risk of displacement
• Radioactive stent: 125I particle stent, combining drainage and local radiotherapy

Technical points:

• Precise positioning: PTC needle punctures the target bile duct to establish a working channel
• Pre-expansion: Balloon dilation of the narrowed segment
• Stent release: Precisely located and released under X-ray guidance
• Post-expansion: Ensure the stent is fully expanded

Product innovation:

• Pre-loaded stent system: Stents are pre-installed in the delivery system, simplifying the operation
• Recoverable stent: Temporary stent, removed by endoscopy after 4-6 weeks
• Drug-eluting stent: Paclitaxel or gemcitabine coating, inhibiting tumor growth

Gallbladder Intervention: A New Option for Percutaneous Gallbladder Treatment

Percutaneous transhepatic gallbladder puncture has unique value in the following situations:

Clinical application:

• Acute cholecystitis: Bile duct fistula for high-risk patients, replacing emergency surgery
• Gallbladder cancer diagnosis: Biopsy for definitive diagnosis
• Gallbladder drainage: Emergency treatment for gallbladder perforation
• Gallbladder stone treatment: Percutaneous gallbladder endoscopy for stone removal

Technological innovation:

• Gallbladder-specific puncture needle: Blunt design, reducing damage to the gallbladder wall
• Expandable sheath: Establishing an 8-10mm working channel, facilitating the passage of instruments
• Integrated drainage system: Puncture and drainage completed in one step

Imaging Guidance Technology Advancement: From 2D to 3D

The success rate of PTC is closely related to imaging guidance technology:

Traditional X-ray guidance:

• Advantages: Real-time dynamic observation, equipment普及
• Limitations: 2D images, lack of depth information
• Improvement: C-arm multi-angle projection, 3D reconstruction

Ultrasound guidance:

• Advantages: Radiation-free, real-time multi-planar imaging
• Limitations: Gas interference, unclear display of deep structures
• Improvement: Contrast-enhanced ultrasound, elastic imaging

CT guidance:

• Advantages: Precise anatomical display, free from gas interference
• Limitations: Non-real-time, high radiation dose
• Improvement: CT fluoroscopy, low-dose scanning

Fusion technology:

• Ultrasound-CT fusion: Combining real-time and accuracy
• Electromagnetic navigation: Real-time tracking of instrument position
• Augmented reality: 3D model superimposed on the patient's body surface

Complication Prevention: Continuous Improvement in Safety

Although PTC technology is mature, complications still need to be paid attention to:

Common complications:

• Hemorrhage: Occurrence rate 1-3%, severe hemorrhage 0.5%
• Bile leakage: Occurrence rate 1-2%, mostly self-limiting
• Infection: Bacteremia occurrence rate 5-10%
• Pneumothorax: Risk of right thoracic puncture

Prevention strategies:

• Preoperative assessment: Coagulation function, platelet count, imaging evaluation
• Technical optimization: Real-time ultrasound-guided puncture, avoiding large blood vessels
• Instrument improvement: Fine needle puncture, one-step system
• Postoperative management: Close monitoring, timely handling

Future Outlook: Intelligent Interventional Era

PTC technology is developing towards intelligence and precision:

Robot-assisted PTC:

• Mechanical arm stable needle holding, reducing the impact of respiratory movement
• Pre-operative planning of the optimal puncture path
• Force feedback system, avoiding excessive puncture

Artificial intelligence application:

• Automatic path planning: Based on CT/MRI data to calculate the optimal path
• Real-time needle tip tracking: Deep learning algorithm identifies the needle tip position
• Complication prediction: Predicting bleeding risk based on operation parameters

Treatment integration:

• Photodynamic therapy: Local treatment of cholangiocarcinoma through PTC channel
• Radiofrequency ablation: Intracavitary ablation of gallbladder tumors
• Radioactive particle implantation: 125I particle strip local radiotherapy
• As a manufacturer of PTC needles, we are not only an equipment provider but also a partner in clinical solutions. By deeply understanding clinical needs and continuously innovating product designs, we strive to offer safer, more effective, and minimally invasive treatment options for patients with biliary diseases. In the era of precision medicine, PTC technology will continue to play an irreplaceable role.